Medrx Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-802.00
-930.00
-1,109.00
-1,058.00
-1,106.00
-1,611.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-91.00
-29.00
-10.00
75.00
70.00
35.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-803.00
-913.00
-1,073.00
-923.00
-985.00
-1,546.00
Cash Flow from Investing Activities
-3.00
0.00
-1.00
-2.00
-5.00
-252.00
Cash Flow from Financing Activities
1,066.00
1,639.00
356.00
815.00
1,393.00
1,414.00
Net Cash Inflow / Outflow
256.00
726.00
-709.00
-108.00
401.00
-386.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-3.00
1.00
9.00
1.00
-1.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Medrx Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
-802.738
-1017.729
215.00
21.12%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-91.762
12.84
-103.00
-814.66%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-803.403
-999.002
196.00
19.58%
Cash Flow from Investing Activities
-3.155
67.178
-70.00
-104.70%
Cash Flow from Financing Activities
1066.994
667.263
399.00
59.91%
Net Cash Inflow / Outflow
256.919
-262.619
518.00
197.83%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-3.517
-0.094
-3.00
-3641.49%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 12.08% vs 14.86% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-803.40
-913.80
12.08%






